about
The Danish National Lymphoma Registry: Coverage and Data QualityVery long-term remission induced by short-term rituximab monotherapy in a patient with heavily pretreated, chronic immune thrombocytopenic purpura.Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma.The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factorTreatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort studyUp-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic studyIncreased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort StudyPrognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort studyDepth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort studyMyeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohortNo differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patientsPretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing ChemotherapyIntravenous but not intrathecal central nervous system-directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma
P50
Q31110238-BF0A2546-B773-40EE-80E2-262ADE3BDF41Q33393344-7B8FE6F8-79CE-4B33-9F79-73408A7D98ADQ38184954-B7094A07-E857-4B66-B38A-32EF1458152FQ38941888-ACF0FA18-464C-469F-968F-3A1269521567Q39342393-7FEE1343-D39F-4387-A04E-CA658CF6B7A7Q41745482-63A46214-41D4-4818-97CE-575CFF5B6528Q52687205-68E76F23-E2D4-4494-9761-A8F642135557Q57048014-CFC1FE15-5D28-4FC8-97A8-2D78D38E53B1Q89211720-519D40A9-5225-494E-9C4B-71EE9238DAF0Q89433522-C2B4DC89-FDD4-4816-84E1-FD445A563337Q89643866-A7815D08-D55C-4CE3-B00C-48CC4C3EBFD5Q90841214-8390947C-58F3-44FD-81B6-50690D4D60C2Q91157212-8711231D-EA81-41A1-B383-33358E0D2B36Q91525090-9F4A22CD-9E41-4E2D-893D-480194B806A9Q91774260-6EDF1CB4-E6FA-4CC3-BD0D-5503BBA6DD98Q91789709-4F4178C4-5E43-4F15-8F21-666A240B329EQ91976999-D3290EA6-17EE-41F7-B274-446B12B6333A
P50
description
researcher ORCID ID = 0000-0003-3218-3633
@en
wetenschapper
@nl
name
Michael R Clausen
@ast
Michael R Clausen
@en
Michael R Clausen
@es
Michael R Clausen
@nl
type
label
Michael R Clausen
@ast
Michael R Clausen
@en
Michael R Clausen
@es
Michael R Clausen
@nl
prefLabel
Michael R Clausen
@ast
Michael R Clausen
@en
Michael R Clausen
@es
Michael R Clausen
@nl
P1153
35739899500
P21
P31
P496
0000-0003-3218-3633